Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Conference item |
| 语言: | English |
| 出版: |
Journal of Rheumatology
2022
|
| 总结: |
|---|